Abzena’s 2nd Biopharmaceutical Discovery & Development Symposium - Abzena

Abzena’s 2nd Biopharmaceutical Discovery & Development Symposium

Babraham Research Campus, Cambridge, UK – Wednesday 19 February 2020

Abzena are hosting the second Biopharmaceutical Discovery & Development Symposium to showcase the latest technologies and advancements in the biologics field. This will include case studies on how these have been successfully used by developers to efficiently and effectively create biopharmaceuticals to address significant unmet medical needs.

Download the full agenda here

Tours of state-of-the-art laboratories

There will also be tours of state-of-the-art laboratories used in Discovery, Immunology, Bioassays, Protein Engineering, Bioconjugation, Bioanalytics and Cell Line Development with demonstrations of how these are used in the drug development process.

The symposium will cover the latest developments in:

  • Antibody Discovery & Design
  • Working with novel formats in antibody development
  • Assessing developability and reducing the risk on route to IND
  • Cell Line Development and improving titre with reduced timelines
  • Antibody Drug Conjugates, evaluating linker-payload options effectively
  • Developing integrated programs and accelerating timelines

Date

19 February 2020

Time

9:30AM – 6:00PM (5PM Networking Reception)

Location

Cambridge Building
Babraham Research Campus
Babraham, Cambridge
CB22 3AT, UK

Transportation

Complimentary transportation is provided between Cambridge Train Station and the venue. Cambridge is easily accessible from Stansted airport which connects to most European airports.

Registration

Registration is free and open to all. Please fill out the registration form below to let us know you are coming.

Selected Speakers 2020

John McCafferty
CEO and Founder
Iontas

John Greenwood
Hugh Davson Professor of Biomedical Research
UCL Institute of Ophthalmology

Nathalie Bellocq
Project Manager &
Debiopharm

Simon Thompson
Executive Vice President &
RxCelerate

Mark Frigerio
VP of Design & Development

Campbell Bunce
Chief Scientific Officer
Abzena

2018 Speakers

Alem Truneh
Chief Technology Officer
ImCheck Therapeutics

Lars Kober
Chief Executive Officer
UGA

Steven Moss
Ashton Professor of Biomedical Research
UCL

Alison Rees-Manley
Product Manager
Sartorius Stedim

Campbell Bunce
Chief Scientific Officer
Abzena

Interested in our services? Get In Touch